 14. Any condition that would make the participant, in the opinion of the Investigator, unsuitable for the study for example, would place a participant at risk or compromise the quality of the data, including participants with a high likelihood of death within 72 hours after randomization despite adequate antimicrobial therapy for HABP or VABP or participants with a do not resuscitate order. 